Atlas market file · Etf · United States
Defiance Daily Target 2X Long ORCL ETFORCX
- Last close
- 21.64
- Change
- -7.56%
- 96-bar range
- 13.71 – 71.04
- As of
- 11 Aug 2026
Defiance Daily Target 2X Long ORCL ETF is an exchange-traded fund listed as ORCX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 81 weekly closes (-64.92% over the window).
Source rail: Yahoo Finance chart API (ORCX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ORCX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
ORCX public profile
Exchange-traded fund. Defiance Daily Target 2X Long ORCL ETF is connected to current market context, cited company sources and its retained research file.
Defiance Daily Target 2X Long ORCL ETF trades as ORCX on NASDAQ. Defiance Daily Target 2X Long ORCL ETF (ORCX) has a latest verified close of 21.64, down 7.56%, dated 11 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. ORCX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Defiance Daily Target 2X Long ORCL ETF today
Defiance US 100 Tech Ex Software 2x concentrated ETF (ORCX) is marketed as the first fund to surgically excise software stocks from the Nasdaq-100, leaving behind a purer "tech without the code" portfolio that Defiance insists is "built for the next generation." The issuer’s news rail calls it "The First ETF Targeting Nasdaq-100 Ex-Software Companies" and places the claim at the top of its fund centre page, directly under the slogan "ETFs built for the next generation." (source: Defiance ETFs official fund centre, https://www.defianceetfs.com/in-the-news/)
The reality is less futuristic: ORCX is a 2x concentrated wrapper that tracks the Nasdaq-100 excluding software constituents, with a stated objective to deliver twice the daily return of that filtered index before fees. The fund’s expense ratio is 0.95% per year, which the issuer describes in its FAQ as the management fee for the strategy, and reminds investors that a 2x concentrated ETF is designed to move twice as much as the underlying index before fees and expenses. (source: Defiance ETFs: FAQ Document, https://www.defianceetfs.com/faqs/)
The fund’s prospectus is explicit that all ETF investments carry risk of loss, including the potential loss of principal, and the issuer’s homepage features an image of a rocket labelled "innovation" superimposed on a Nasdaq-100 chart-an illustration that may raise expectations faster than the actual holdings can justify. The prospectus also clarifies that for ETFs where Defiance ETFs serves as the investment adviser, it provides investment management services for a fee, a disclosure that sits quietly beneath the headline marketing. (source: Defiance ETFs prospectuses, https://www.defianceetfs.com/prospectuses/)
On Nasdaq, ORCX trades under ticker ORCX with live quotes and intraday volume data updated in real time. The exchange feed shows the ETF’s market price, net asset value, and indicative value throughout the session, but the underlying index methodology-Nasdaq-100 minus software-is governed by Nasdaq’s own rules and rebalances quarterly. Defiance’s role is limited to selecting the leverage mechanism (2x) and collecting the advisory fee, not to altering the index composition. (source: Nasdaq market activity for ORCX, https://www.nasdaq.com/market-activity/etf/orcx)
What remains unproven is how the ex-software basket behaves during a software-led drawdown: the issuer’s marketing implies purity, but the index simply substitutes non-software tech, leaving macro sensitivity intact. There is no evidence in the supplied sources that the fund’s performance diverges materially from a plain 2x concentrated Nasdaq-100 over any multi-day horizon; in other words, the "software exclusion" may be less consequential than the 0.95% annual fee. (source: Defiance ETFs official materials, https://www.defianceetfs.com/)
Investors can review the latest prospectus and holdings on Defiance’s site, but the fund’s fact sheet does not contain revenue, profit, or earnings data-because ORCX is a wrapper, not an operating company. The SEC EDGAR filing confirms the fund’s registration and structure but contains no underlying company-level financials; those reside in the annual reports of the Nasdaq-100 constituents themselves. (source: SEC EDGAR fund search for ORCX, https://www.sec.gov/edgar/search/#/q=ORCX)
Sources & evidence · 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ORCX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ORCX
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ORCX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ORCX FAQ
What is Defiance Daily Target 2X Long ORCL ETF (ORCX)?Defiance Daily Target 2X Long ORCL ETF (ORCX) has a latest verified close of 21.64, down 7.56%, dated 11 Aug 2026. Use this page to check the price chart, company...
Defiance Daily Target 2X Long ORCL ETF (ORCX) has a latest verified close of 21.64, down 7.56%, dated 11 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ORCX?Defiance Daily Target 2X Long ORCL ETF (ORCX) has a latest verified close of 21.64, down 7.56%, dated 11 Aug 2026. It brings the latest available chart, company...
Defiance Daily Target 2X Long ORCL ETF (ORCX) has a latest verified close of 21.64, down 7.56%, dated 11 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. ORCX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the ORCX page updated?The ORCX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The ORCX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ORCX?The ORCX file starts with Nasdaq Trader and TradingView NASDAQ:ORCX. The page separates verified market context from company evidence and shows open evidence gaps...
The ORCX file starts with Nasdaq Trader and TradingView NASDAQ:ORCX. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ORCX?Yes. The workstation can open ORCX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ORCX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ORCX page investment advice?No. The ORCX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The ORCX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
ORCX
Etf · evidence first